ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastrointestinal, Liver, Effusion, and Renal Safety Characterization in the BFORE Trial
By
ASCO 2022 Conference Coverage
FEATURING
Jorge Cortés
By
ASCO 2022 Conference Coverage
FEATURING
Jorge Cortés
Login to view comments.
Click here to Login
Leukemia